FDA Approves First Tocilizumab Biosimilar FDA Approves First Tocilizumab Biosimilar

Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.FDA Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Alert Source Type: news